#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Inborn error of metabolism Small intestine neuroendocrine tumour Chronic graft versus host disease in intestine Idiopathic inflammatory myopathy Liver transplant rejection Adrenoleukodystrophy Dedifferentiated liposarcoma Haemophagocytic lymphohistiocytosis Huntington's disease Erythema Small for dates baby Castleman's disease Arterial disorder Burkitt's lymphoma Activated PI3 kinase delta syndrome More trials…

    Learn about Rare Diseases

    Idiopathic pulmonary fibrosis – Basic Information Crigler-Najjar syndrome – Life with Disease Nephroblastoma – Basic Information Indolent systemic mastocytosis – Basic Information Turner’s syndrome – Life with Disease Glomerulonephritis membranous Prader-Willi syndrome – Basic Information Pemphigoid – Life with Disease Pituitary-dependent Cushing’s syndrome – Diagnostics Sarcoma – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Namilumab Lolium Perenne Cefuroxime Axetil Palmidrol Benzylpenicillin Sodium Rozanolixizumab BENZYLPENICILLIN POTASSIUM Glucose, Anhydrous Rosuvastatin Calcium Soticlestat Citicoline Sodium Gemtuzumab Ozogamicin Ganciclovir Sodium VORMATRIGINE Ads-015 Ivabradine Hydrochloride Etamsylate L-Arginine Hydrochloride ABBV-CLS-628 Gozetotide More therapies…

    Learn about Your Condition

    Latent tuberculosis Toxic nodular goitre Plasma cell myeloma refractory Follicular lymphoma stage II Hernia repair Rheumatic disorder Viral infection Endometrial cancer stage III B-cell lymphoma refractory Cervix carcinoma stage III Erosive oesophagitis Osteomyelitis Noninfective chorioretinitis Systemic scleroderma Rectal neoplasm More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Otorhinolaryngologic Diseases

  • Study on Symptom Changes in Adults with Chronic Rhinosinusitis with Nasal Polyps Using Tezepelumab

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Tezepelumab
    Bulgaria France Germany Hungary Italy Poland +1

  • Study on the Effects of PF-07976016 and Liraglutide in Adults with Obesity

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • Liraglutide
    Hungary Poland

  • Study on Stopping Mepolizumab or Dupilumab in Patients with Severe Chronic Rhinosinusitis with Nasal Polyps After 12 Months Symptom-Free

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic rhinosinusitis with nasal polyps
    Investigated Drugs:
    • Mepolizumab
    • Dupilumab
    Denmark

  • Study of Lebrikizumab and Mometasone Furoate for Adults with Perennial Allergic Rhinitis

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Rhinitis allergic
    Investigated Drugs:
    • Lebrikizumab
    • Mometasone Furoate
    Belgium Germany Poland

  • Study on SENS-401 to Prevent Hearing Loss Caused by Cisplatin in Adults with Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Deafness
    Investigated Drugs:
    • R-Azasetron Besilate
    France

  • Study on the Effects of IO102 Hydrochloride and IO103 Acetate for Patients with Head and Neck Cancer

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Squamous cell carcinoma of head and neck
    Investigated Drugs:
    • Io102 Hydrochloride
    • Io103 Acetate
    Belgium
Previous Page
1 … 7 8 9 10 11
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!